Administering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.

GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the ...

The panel expressed concerns about the proposed doses of Blenrep (belantamab mafodotin) in GSK's marketing application, ...

FTSE 100 Live Friday Reckitt sells Cillit BangBurberry hails progressBP sells onshore wind business Market update: GSK falls 6% on FDA setback, Burberry ...

The jet maker said it has agreed to sell 12 of the aircraft to the airline, with options for six more. The British pharmaceutical company said combinations for its Blenrep drug were evaluated in ...

Another week where the market has traded in a narrow range comes to an end today. The Nifty, so far, is down 38 points for ...

As new treatments for systemic lupus erythematosus and lupus nephritis enter the armamentarium, revitalizing the management ...